Charles Chavkin

21.6k total citations · 4 hit papers
197 papers, 17.5k citations indexed

About

Charles Chavkin is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Charles Chavkin has authored 197 papers receiving a total of 17.5k indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Cellular and Molecular Neuroscience, 152 papers in Molecular Biology and 34 papers in Physiology. Recurrent topics in Charles Chavkin's work include Neuropeptides and Animal Physiology (135 papers), Receptor Mechanisms and Signaling (119 papers) and Neuroscience and Neuropharmacology Research (63 papers). Charles Chavkin is often cited by papers focused on Neuropeptides and Animal Physiology (135 papers), Receptor Mechanisms and Signaling (119 papers) and Neuroscience and Neuropharmacology Research (63 papers). Charles Chavkin collaborates with scholars based in United States, France and Czechia. Charles Chavkin's co-authors include Michael R. Bruchas, Avram Goldstein, Jay P. McLaughlin, Benjamin B. Land, Iain F. James, Mei Xu, Monica Marton-Popovici, Jeremy Celver, Michele L. Simmons and Abraham Kovoor and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Charles Chavkin

195 papers receiving 17.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor

1982 1.0k citations Charles Chavkin et al. profile →
Regulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance

2013 624 citations Charles Chavkin et al. profile →
Regulation of Gonadotropin-Releasing Hormone Secretion by Kisspeptin/Dynorphin/Neurokinin B Neurons in the Arcuate Nucleus of the Mouse

2009 609 citations Charles Chavkin et al. Journal of Neuroscience profile →
Induction of CRE-Mediated Gene Expression by Stimuli That Generate Long-Lasting LTP in Area CA1 of the Hippocampus

1996 501 citations Soren Impey, Melanie D. Mark et al. Neuron profile →

Peers

Countries citing papers authored by Charles Chavkin

Since Specialization

Citations

This map shows the geographic impact of Charles Chavkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Chavkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Chavkin more than expected).

Fields of papers citing papers by Charles Chavkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Chavkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Chavkin. The network helps show where Charles Chavkin may publish in the future.

Co-authorship network of co-authors of Charles Chavkin

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Chavkin. A scholar is included among the top collaborators of Charles Chavkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Chavkin. Charles Chavkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	G Protein Inactivation as a Mechanism for Addiction Treatment 2025 ·Biological Psychiatry ·(unknown), (unknown), (unknown), C. Justin Lee, Benjamin B. Land, A. Berndt, Charles Chavkin	0
2	Stress decreases serotonin tone in the nucleus accumbens in male mice to promote aversion and potentiate cocaine preference via decreased stimulation of 5-HT1B receptors 2021 ·Neuropsychopharmacology ·(unknown), (unknown), (unknown), (unknown), Antony D. Abraham, Benjamin B. Land, John F. Neumaier, Charles Chavkin	15
3	Release of endogenous dynorphin opioids in the prefrontal cortex disrupts cognition 2021 ·Neuropsychopharmacology ·Antony D. Abraham, (unknown), Selena S. Schattauer, (unknown), Grace O. Mizuno, (unknown), Lin Tian, Benjamin B. Land, Charles Chavkin	48
4	Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion 2018 ·Journal of Neuroscience ·Antony D. Abraham, Selena S. Schattauer, (unknown), (unknown), (unknown), Allisa J. Song, (unknown), Benjamin B. Land, Charles Chavkin	60
5	Peroxiredoxin 6 mediates Gαi protein-coupled receptor inactivation by cJun kinase 2017 ·Nature Communications ·Selena S. Schattauer, Benjamin B. Land, (unknown), Antony D. Abraham, Lauren M. Burgeno, (unknown), Paul E. M. Phillips, (unknown), Charles Chavkin	40
6	Kappa Opioid Receptor Activation Potentiates the Cocaine-Induced Increase in Evoked Dopamine Release Recorded In Vivo in the Mouse Nucleus Accumbens 2014 ·Neuropsychopharmacology ·(unknown), Paul E. M. Phillips, Charles Chavkin	50
7	Repeated Stress Dysregulates κ-Opioid Receptor Signaling in the Dorsal Raphe through a p38α MAPK-Dependent Mechanism 2012 ·Journal of Neuroscience ·Julia C. Lemos, (unknown), Daniel I. Messinger, (unknown), Paul E. M. Phillips, Charles Chavkin	47
8	α-Dystrobrevin-1 recruits α-catulin to the α _1D -adrenergic receptor/dystrophin-associated protein complex signalosome 2010 ·Proceedings of the National Academy of Sciences ·John S. Lyssand, (unknown), (unknown), (unknown), Jennifer L. Wacker, Michael R. Bruchas, Mayumi Miyatake, Lorene K. Langeberg, Charles Chavkin, John D. Scott, Richard G. Gardner, Marvin E. Adams, Chris Hague	28
9	Phosphorylation of the μ-Opioid Receptor at Tyrosine 166 (Tyr3.51) in the DRY Motif Reduces Agonist Efficacy 2009 ·Molecular Pharmacology ·(unknown), Michael R. Bruchas, Michael L. Lee, Charles Chavkin	28
10	Effects of acute agonist treatment on subcellular distribution of κ opioid receptor in rat spinal cord 2009 ·Journal of Neuroscience Research ·Yu‐Lin Wang, Wei Xu, Peng Huang, Charles Chavkin, Elisabeth J. Van Bockstaele, (unknown)	14
11	The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System 2008 ·Journal of Neuroscience ·Benjamin B. Land, Michael R. Bruchas, Julia C. Lemos, Mei Xu, Erica J. Melief, Charles Chavkin	475
12	Long-Acting κ Opioid Antagonists Disrupt Receptor Signaling And Produce Noncompetitive Effects By Activating C-Jun N-Terminal Kinase 2007 ·Journal of Biological Chemistry ·Michael R. Bruchas, Tao Yang, (unknown), Mia C. DeFino, (unknown), Shuang Li, Charles Chavkin	158
13	Decreased Substance P and NK1 Receptor Immunoreactivity and Function in the Spinal Cord Dorsal Horn of Morphine-Treated Neonatal Rats 2007 ·Journal of Pain ·(unknown), Gregory W. Terman, Jinsong Zeng, Janet Lowe, Charles Chavkin, Sam M. Hermes, Deborah M. Hegarty, Sue A. Aicher	13
14	κ Opioid Receptor Antagonism and Prodynorphin Gene Disruption Block Stress-Induced Behavioral Responses 2003 ·Journal of Neuroscience ·Jay P. McLaughlin, Monica Marton-Popovici, Charles Chavkin	377
15	Administered and Endogenously Released Kappa Opioids Decrease Pilocarpine-Induced Seizures and Seizure-Induced Histopathology 1998 ·Journal of Pharmacology and Experimental Therapeutics ·Suzanne B. Bausch, (unknown), Gregory W. Terman, Charles Chavkin	32
16	Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. 1998 ·PubMed ·Abraham Kovoor, Jeremy Celver, Albert Y. Wu, Charles Chavkin	115
17	μ and δ Opioid Receptors Are Differentially Desensitized by the Coexpression of β-Adrenergic Receptor Kinase 2 and β-Arrestin 2 in Xenopus Oocytes 1997 ·Journal of Biological Chemistry ·Abraham Kovoor, (unknown), Brigitte L. Kieffer, Charles Chavkin	125
18	Kappa opioid receptor-like immunoreactivity is present in substance P-containing subcortical afferents in guinea pig dentate gyrus 1997 ·Hippocampus ·Carrie T. Drake, Charles Chavkin, Teresa A. Milner	15
19	Induction of CRE-Mediated Gene Expression by Stimuli That Generate Long-Lasting LTP in Area CA1 of the Hippocampus breakdown → 1996 ·Neuron ·Soren Impey, Melanie D. Mark, Enrique C. Villacres, Steven Poser, Charles Chavkin, Daniel R. Storm	501
20	L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells 1995 ·Neuron ·Michele L. Simmons, Gregory W. Terman, Sarah Gibbs, Charles Chavkin	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact